Jacobs Levy Equity Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Jacobs Levy Equity Management’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-52,753	Closed	-$109K	–	908
2015 Q1	$109K	Buy	+52,753	New	+$108K	﹤0.01%	744
2014 Q3	–	Sell	-23,100	Closed	-$106K	–	977
2014 Q2	$106K	Buy	23,100 +10,600	+85%	+$45.8K	﹤0.01%	800
2014 Q1	$55K	Buy	+12,500	New	+$64.1K	﹤0.01%	870

Other funds holding ALXA

LPA

Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return

HHMI

Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Jacobs Levy Equity Management's ALXA Position: Q2 2015 in Review

Jacobs Levy Equity Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2015, closing a stake of 52,753 shares — an estimated $109K sold.

Jacobs Levy Equity Management first reported a position in ALXA in Q1 2014 and held it in 3 quarters. The position peaked at $109K in Q1 2015. 22 funds tracked by Wall St. Rank hold ALXA as of Q2 2015.

Jacobs Levy Equity Management reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
Jacobs Levy Equity Management sold 52,753 Alexza Pharmaceuticals Inc shares in Q2 2015, an estimated $109K.
Jacobs Levy Equity Management first reported a position in Alexza Pharmaceuticals Inc in Q1 2014 and held it in 3 quarters.
Jacobs Levy Equity Management's Alexza Pharmaceuticals Inc position peaked at $109K in Q1 2015.
22 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2015.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.